ROYALTY INTEREST ASSIGNMENT AGREEMENT between EPOCH BIOSCIENCES, INC. as Assignor and DRUG ROYALTY LP2 as Assignee March 28, 2008Royalty Interest Assignment Agreement • May 12th, 2008 • Nanogen Inc • Laboratory analytical instruments • New York
WHEREAS Assignor is a party to a Second Amended and Restated Collaboration, License and Supply Agreement with Applera Corporation (the “Licensee”) dated as of August 17, 2000, as amended by the First Side Agreement dated October 31, 2001, the Amendment No. 1 to the Second Amended and Restated Collaboration, License and Supply Agreement dated July 26, 2002 and Amendment No. 2 to the Second Amended and Restated Collaboration, License and Supply Agreement dated as of December 31, 2005 (collectively, the “License Agreement”);
ROYALTY INTEREST ASSIGNMENT AGREEMENTRoyalty Interest Assignment Agreement • August 29th, 2006 • Dyax Corp • Services-commercial physical & biological research • New York
This opinion is rendered to you in connection with the Royalty Interest Assignment Agreement and the transactions contemplated thereby and is solely for the benefit of PRF and its successors and assigns of the Assigned Interests. Except as aforesaid, this opinion may not be relied upon by you for any other purpose, or relied upon by any other person, firm, corporation or other entity for any purpose without my prior consent, but without limiting the terms of any Transaction Document. I disclaim any obligation to advise you of any change of law that occurs, or any facts of which I may become aware, after the date of this opinion.
ROYALTY INTEREST ASSIGNMENT AGREEMENT between EPOCH BIOSCIENCES, INC. as Assignor and DRUG ROYALTY TRUST 9 as Assignee and NANOGEN, INC. as Guarantor September 29, 2006Royalty Interest Assignment Agreement • November 9th, 2006 • Nanogen Inc • Laboratory analytical instruments • New York
WHEREAS Assignor is a party to a Second Amended and Restated Collaboration, License and Supply agreement with Applera Corporation (the “Licensee”) dated as of August 17, 2000, as amended by the First Side Agreement dated October 31, 2001, the Amendment No. 1 to the Second Amended and Restated Collaboration, License and Supply Agreement dated July 26, 2002 and Amendment No. 2 to the Second Amended and Restated Collaboration, License and Supply Agreement dated as of December 31, 2005 (as amended, the “License Agreement”);
